Balance Sheet: Liabilities and Stockholders’ Equity

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

Edwards Lifesciences Corp., consolidated balance sheet: liabilities and stockholders’ equity

US$ in thousands

	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Accounts payable	204,500)	196,500)	180,400)	134,000)	116,600)
Employee compensation and withholdings	319,700)	236,700)	295,800)	226,100)	249,400)
Accrued rebates	77,000)	67,200)	67,100)	80,000)	53,900)
Property, payroll, and other taxes	68,900)	49,700)	51,400)	39,500)	41,900)
Research and development accruals	58,200)	52,300)	51,400)	48,900)	39,200)
Legal and insurance	79,100)	60,800)	20,000)	196,700)	15,000)
Taxes payable	30,600)	18,600)	52,900)	31,300)	97,800)
Fair value of derivatives	3,900)	39,300)	6,400)	4,400)	24,800)
Accrued marketing expenses	20,100)	14,300)	17,500)	22,300)	14,900)
Accrued professional services	11,900)	7,600)	10,100)	11,000)	8,500)
Accrued realignment reserves	19,100)	14,500)	16,700)	100)	8,200)
Accrued relocation costs	26,200)	21,000)	17,400)	11,300)	8,700)
Other accrued liabilities	87,600)	88,200)	89,800)	71,000)	74,300)
Accrued and other liabilities	802,300)	670,200)	696,500)	742,600)	636,600)
Operating lease liabilities, current portion	25,500)	27,200)	25,500)	—)	—)
Short-term debt	—)	—)	—)	—)	598,000)
Contingent consideration liabilities	—)	—)	—)	—)	51,700)
Current liabilities	1,032,300)	893,900)	902,400)	876,600)	1,402,900)
Long-term debt	595,700)	595,000)	594,400)	593,800)	438,400)
Contingent consideration liabilities	62,000)	186,100)	172,500)	178,600)	192,600)
Taxes payable	190,000)	215,300)	236,600)	259,400)	394,000)
Operating lease liabilities, long-term portion	69,100)	72,700)	58,900)	—)	—)
Uncertain tax positions	259,000)	214,400)	171,700)	124,900)	164,600)
Litigation settlement accrual	191,300)	233,000)	—)	—)	—)
Other liabilities	267,300)	252,400)	203,300)	150,000)	147,100)
Long-term liabilities	1,634,400)	1,768,900)	1,437,400)	1,306,700)	1,336,700)
Total liabilities	2,666,700)	2,662,800)	2,339,800)	2,183,300)	2,739,600)
Preferred stock, $.01 par value, no shares outstanding	—)	—)	—)	—)	—)
Common stock, $1.00 par value	642,000)	636,400)	218,100)	215,200)	212,000)
Additional paid-in capital	1,700,400)	1,438,100)	1,623,300)	1,384,400)	1,166,900)
Retained earnings	6,068,100)	4,565,000)	3,741,600)	2,694,700)	1,962,100)
Accumulated other comprehensive loss	(157,700)	(161,100)	(156,000)	(138,500)	(132,700)
Treasury stock, at cost	(2,416,900)	(1,904,100)	(1,278,700)	(1,015,400)	(252,100)
Stockholders’ equity	5,835,900)	4,574,300)	4,148,300)	3,140,400)	2,956,200)
Total liabilities and stockholders’ equity	8,502,600)	7,237,100)	6,488,100)	5,323,700)	5,695,800)

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

Download chart

Balance sheet item	Description	The company
Current liabilities	Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.	Edwards Lifesciences Corp. current liabilities decreased from 2019 to 2020 but then increased from 2020 to 2021 exceeding 2019 level.
Long-term liabilities	Amount of obligation due after one year or beyond the normal operating cycle, if longer.	Edwards Lifesciences Corp. long-term liabilities increased from 2019 to 2020 but then slightly decreased from 2020 to 2021.
Total liabilities	Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.	Edwards Lifesciences Corp. total liabilities increased from 2019 to 2020 and from 2020 to 2021.
Stockholders’ equity	Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.	Edwards Lifesciences Corp. stockholders’ equity increased from 2019 to 2020 and from 2020 to 2021.

Edwards Lifesciences Corp. (NYSE:EW)

Balance Sheet: Liabilities and Stockholders’ Equity